Sonnet BioTherapeutics is no longer just a cancer drug developer. Its $888 million merger will place it among the largest HYPE holders, blurring the lines between traditional finance and decentralized protocols in a high-stakes treasury experiment. According to a July…
Related Posts
Stars Arena recovers 90% of exploited funds after onchain negotiations
Stars Arena negotiated with the attacker over the course of four days, eventually recovering 90% of funds in…
PEPE up by over 40% in last 24 hours
Pepe, a memecoin, has increased by over 80% in value amidst a general downturn in the crypto market,…
Uniswap will deploy on Polkadot parachain Moonbeam
The decentralized exchange gets a Polkadot version via the Moonbeam network.